TY - JOUR AU - Banna, G. L. AU - Simonelli, M. AU - Santoro, A. PY - 2007 DA - 2007// TI - High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review JO - Curr Stem Cell Res Ther VL - 2 UR - https://doi.org/10.2174/157488807779316964 DO - 10.2174/157488807779316964 ID - Banna2007 ER - TY - JOUR AU - Ladenstein, R. AU - Philip, T. AU - Gardner, H. PY - 1997 DA - 1997// TI - Autologous stem cell transplantation for solid tumors in children JO - Curr Opin Pediatr VL - 9 UR - https://doi.org/10.1097/00008480-199702000-00013 DO - 10.1097/00008480-199702000-00013 ID - Ladenstein1997 ER - TY - JOUR AU - Frei, E. AU - Teicher, B. A. AU - Holden, S. A. AU - Cathcart, K. N. AU - Wang, Y. Y. PY - 1988 DA - 1988// TI - Preclinical studies and clinical correlation of the effect of alkylating dose JO - Cancer Res VL - 48 ID - Frei1988 ER - TY - JOUR AU - Finlay, J. L. AU - Goldman, S. AU - Wong, M. C. AU - Cairo, M. AU - Garvin, J. AU - August, C. AU - Cohen, B. H. AU - Stanley, P. AU - Zimmerman, R. A. AU - Bostrom, B. AU - Geyer, J. R. AU - Harris, R. E. AU - Sanders, J. AU - Yates, A. J. AU - Boyett, J. M. AU - Packer, R. J. PY - 1996 DA - 1996// TI - Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's cancer group JO - J Clin Oncol VL - 14 UR - https://doi.org/10.1200/JCO.1996.14.9.2495 DO - 10.1200/JCO.1996.14.9.2495 ID - Finlay1996 ER - TY - JOUR AU - Ridola, V. AU - Grill, J. AU - Doz, F. AU - Gentet, J. C. AU - Frappaz, D. AU - Raquin, M. A. AU - Habrand, J. L. AU - Sainte-Rose, C. AU - Valteau-Couanet, D. AU - Kalifa, C. PY - 2007 DA - 2007// TI - High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy JO - Cancer VL - 110 UR - https://doi.org/10.1002/cncr.22761 DO - 10.1002/cncr.22761 ID - Ridola2007 ER - TY - JOUR AU - Saarinen-Pihkala, U. M. AU - Hovi, L. AU - Koivusalo, A. AU - Jahnukainen, K. AU - Karikoski, R. AU - Sariola, H. AU - Wikström, S. PY - 2012 DA - 2012// TI - Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma JO - Pediatr Blood Cancer VL - 59 UR - https://doi.org/10.1002/pbc.24173 DO - 10.1002/pbc.24173 ID - Saarinen-Pihkala2012 ER - TY - JOUR AU - Saarinen, U. M. AU - Pihko, H. AU - Makipernaa, A. PY - 1990 DA - 1990// TI - High-dose thiotepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: a case report JO - J Neuro-Oncol VL - 9 UR - https://doi.org/10.1007/BF00167069 DO - 10.1007/BF00167069 ID - Saarinen1990 ER - TY - JOUR AU - Saarinen, U. M. AU - Hovi, L. AU - Makipernaa, A. AU - Riikonen, P. PY - 1991 DA - 1991// TI - High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors JO - Bone Marrow Transplant VL - 8 ID - Saarinen1991 ER - TY - JOUR AU - Tabone, M. D. AU - Kalifa, C. AU - Rodary, C. AU - Raquin, M. AU - Valteau-Couanet, D. AU - Lemerle, J. PY - 1994 DA - 1994// TI - Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy JO - J Clin Oncol VL - 12 UR - https://doi.org/10.1200/JCO.1994.12.12.2614 DO - 10.1200/JCO.1994.12.12.2614 ID - Tabone1994 ER - TY - JOUR AU - Huitema, A. D. AU - Mathot, R. A. AU - Tibben, M. M. AU - Schellens, J. H. AU - Rodenhuis, S. AU - Beijnen, J. H. PY - 2001 DA - 2001// TI - Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy JO - Br J Clin Pharmacol VL - 51 UR - https://doi.org/10.1046/j.1365-2125.2001.01301.x DO - 10.1046/j.1365-2125.2001.01301.x ID - Huitema2001 ER - TY - STD TI - Miller B, Tenenholz T, Egorin MJ, Sosnovsky G, Rao NU, Gutierrez PL. Cellular pharmacology of N,N',N”-triethylene thiophosphoramide. Cancer Lett 1988;41:157–168. ID - ref11 ER - TY - JOUR AU - Jacobson, P. A. AU - Green, K. AU - Birnbaum, A. AU - Remmel, R. P. PY - 2002 DA - 2002// TI - Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA JO - Cancer Chemother Pharmacol VL - 49 UR - https://doi.org/10.1007/s00280-002-0453-3 DO - 10.1007/s00280-002-0453-3 ID - Jacobson2002 ER - TY - JOUR AU - Dirven, H. A. AU - Dictus, E. L. AU - Broeders, N. L. AU - van Ommen, B. AU - van Bladeren, P. J. PY - 1995 DA - 1995// TI - The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa JO - Cancer Res VL - 55 ID - Dirven1995 ER - TY - JOUR AU - Heideman, R. L. AU - Packer, R. J. AU - Reaman, G. H. AU - Allen, J. C. AU - Lange, B. AU - Horowitz, M. E. AU - Steinberg, S. M. AU - Gillespie, A. AU - Kovnar, E. H. AU - Balis, F. M. PY - 1993 DA - 1993// TI - A phase II evaluation of thiotepa in pediatric central nervous system malignancies JO - Cancer VL - 72 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Heideman1993 ER - TY - STD TI - Maanen MJ, Smeets CJ, Beijnen JH. Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA). Cancer Treat Rev 2000;26:257–268. ID - ref15 ER - TY - JOUR AU - Cohen, B. E. AU - Egorin, M. J. AU - Kohlhepp, E. A. AU - Aisner, J. AU - Gutierrez, P. L. PY - 1986 DA - 1986// TI - Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites JO - Cancer Treat Rep VL - 70 ID - Cohen1986 ER - TY - JOUR AU - Ekhart, C. AU - Doodeman, V. D. AU - Rodenhuis, S. AU - Smits, P. H. AU - Beijnen, J. H. AU - Huitema, A. D. PY - 2009 DA - 2009// TI - Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa JO - Br J Clin Pharmacol VL - 67 UR - https://doi.org/10.1111/j.1365-2125.2008.03321.x DO - 10.1111/j.1365-2125.2008.03321.x ID - Ekhart2009 ER - TY - STD TI - Herzig R, Brown R, Fay J. Phase I and II studies of high dose N,N′,N″-triethylene thiophosphoramide and autologous marrow transplantation in patients with refractory malignancies. Cancer Res Ther Control 1990;1:141–153. ID - ref18 ER - TY - JOUR AU - Lucidarme, N. AU - Valteau-Couanet, D. AU - Oberlin, O. AU - Couanet, D. AU - Kalifa, C. AU - Beaujean, F. AU - Lapierre, V. AU - Hartmann, O. PY - 1998 DA - 1998// TI - Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors JO - Bone Marrow Transplant VL - 22 UR - https://doi.org/10.1038/sj.bmt.1701395 DO - 10.1038/sj.bmt.1701395 ID - Lucidarme1998 ER - TY - JOUR AU - Przepiorka, D. AU - Madden, T. AU - Ippoliti, C. AU - Estrov, Z. AU - Dimopoulos, M. PY - 1995 DA - 1995// TI - Dosing of thioTEPA for myeloablative therapy JO - Cancer Chemother Pharmacol VL - 37 UR - https://doi.org/10.1007/BF00685643 DO - 10.1007/BF00685643 ID - Przepiorka1995 ER - TY - STD TI - Wolff SN, Herzig RH, Fay JW, LeMaistre CF, Brown RA, Frei-Lahr D, Stranjord S, Giannone L, Coccia P, Weick JL. High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin Oncol 1990;17:2–6. ID - ref21 ER - TY - JOUR AU - Lazarus, H. M. AU - Reed, M. D. AU - Spitzer, T. R. AU - Rabaa, M. S. AU - Blumer, J. L. PY - 1987 DA - 1987// TI - High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer JO - Cancer Treat Rep VL - 71 ID - Lazarus1987 ER - TY - JOUR AU - Schwartz, G. J. AU - Haycock, G. B. AU - Edelmann, C. M. AU - Spitzer, A. PY - 1976 DA - 1976// TI - A Simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine JO - Pediatrics VL - 58 ID - Schwartz1976 ER - TY - JOUR AU - Begaud, B. PY - 2000 DA - 2000// TI - Criteria of imputability in accidents of drug-induced origin JO - Rev Prat VL - 50 ID - Begaud2000 ER - TY - JOUR AU - Freilich, R. J. AU - Delattre, J. Y. AU - Monjour, A. AU - DeAngelis, L. M. PY - 1996 DA - 1996// TI - Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients JO - Neurology VL - 46 UR - https://doi.org/10.1212/WNL.46.2.435 DO - 10.1212/WNL.46.2.435 ID - Freilich1996 ER - TY - JOUR AU - Weiss, H. D. AU - Walker, M. D. AU - Wiernik, P. H. PY - 1974 DA - 1974// TI - Neurotoxicity of commonly used antineoplastic agents (first of two parts) JO - N Engl J Med VL - 291 UR - https://doi.org/10.1056/NEJM197407112910205 DO - 10.1056/NEJM197407112910205 ID - Weiss1974 ER - TY - JOUR AU - Kaplan, R. S. AU - Wiernik, P. H. PY - 1982 DA - 1982// TI - Neurotoxicity of antineoplastic drugs JO - Semin Oncol VL - 9 ID - Kaplan1982 ER - TY - JOUR AU - Kalifa, C. AU - Hartmann, O. AU - Demeocq, F. AU - Vassal, G. AU - Couanet, D. AU - Terrier-Lacombe, M. J. AU - Valteau, D. AU - Brugieres, L. AU - Lemerle, J. PY - 1992 DA - 1992// TI - High-dose Busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study JO - Bone Marrow Transplant VL - 9 ID - Kalifa1992 ER - TY - JOUR AU - Hara, J. AU - Osugi, Y. AU - Ohta, H. AU - Matsuda, Y. AU - Nakanishi, K. AU - Takai, K. AU - Fujisaki, H. AU - Tokimasa, S. AU - Fukuzawa, M. AU - Okada, A. AU - Okada, S. PY - 1998 DA - 1998// TI - Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors JO - Bone Marrow Transplant VL - 22 UR - https://doi.org/10.1038/sj.bmt.1701283 DO - 10.1038/sj.bmt.1701283 ID - Hara1998 ER - TY - JOUR AU - Antman, K. AU - Eder, J. P. AU - Elias, A. AU - Ayash, L. AU - Shea, T. C. AU - Weissman, L. AU - Critchlow, J. AU - Schryber, S. M. AU - Begg, C. AU - Teicher, B. A. PY - 1990 DA - 1990// TI - High-dose thiotepa alone and in combination regimens with bone marrow support JO - Semin Oncol VL - 17 ID - Antman1990 ER - TY - JOUR AU - Kramer, E. D. AU - Packer, R. J. AU - Ginsberg, J. AU - Goldman, S. AU - Thompson, S. AU - Bayer, L. A. AU - Shen, V. AU - Harris, R. AU - Khan, S. AU - Finlay, J. L. PY - 1997 DA - 1997// TI - Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors JO - Pediatr Neurosurg VL - 27 UR - https://doi.org/10.1159/000121259 DO - 10.1159/000121259 ID - Kramer1997 ER - TY - JOUR AU - Orbach, D. AU - Brisse, H. AU - Doz, F. PY - 2003 DA - 2003// TI - Central neurological manifestations during chemotherapy in children JO - Arch Pediatr VL - 10 UR - https://doi.org/10.1016/S0929-693X(03)00105-2 DO - 10.1016/S0929-693X(03)00105-2 ID - Orbach2003 ER - TY - JOUR AU - Provenzale, J. M. AU - Mukundan, S. AU - Dewhirst, M. PY - 2005 DA - 2005// TI - The role of blood-brain barrier permeability in brain tumor imaging and therapeutics JO - AJR Am J Roentgenol VL - 185 UR - https://doi.org/10.2214/ajr.185.3.01850763 DO - 10.2214/ajr.185.3.01850763 ID - Provenzale2005 ER - TY - JOUR AU - Deeken, J. F. AU - Loscher, W. PY - 2007 DA - 2007// TI - The blood-brain barrier and cancer: transporters, treatment, and Trojan horses JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2854 DO - 10.1158/1078-0432.CCR-06-2854 ID - Deeken2007 ER - TY - JOUR AU - Ekhart, C. AU - Kerst, J. M. AU - Rodenhuis, S. AU - Beijnen, J. H. AU - Huitema, A. D. PY - 2009 DA - 2009// TI - Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency JO - Cancer Chemother Pharmacol VL - 63 UR - https://doi.org/10.1007/s00280-008-0757-z DO - 10.1007/s00280-008-0757-z ID - Ekhart2009 ER - TY - STD TI - Richter T, Schwab M, Eichelbaum M, Zanger UM. Inhibition of human CYP2B6 by N,N',N”-triethylenethiophosphoramide is irreversible and mechanism-based. Biochem Pharmacol 2005;69:517–524. ID - ref36 ER - TY - JOUR AU - Nelson, E. M. AU - Philbrick, A. M. PY - 2012 DA - 2012// TI - Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors JO - Ann Pharmacother VL - 46 UR - https://doi.org/10.1345/aph.1Q748 DO - 10.1345/aph.1Q748 ID - Nelson2012 ER - TY - JOUR AU - de Jonge, M. E. AU - Huitema, A. D. AU - Holtkamp, M. J. AU - van Dam, S. M. AU - Beijnen, J. H. AU - Rodenhuis, S. PY - 2005 DA - 2005// TI - Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism JO - Cancer Chemother Pharmacol VL - 56 UR - https://doi.org/10.1007/s00280-005-1005-4 DO - 10.1007/s00280-005-1005-4 ID - de Jonge2005 ER - TY - JOUR AU - Howell, J. E. AU - Szabatura, A. H. AU - Hatfield Seung, A. AU - Nesbit, S. A. PY - 2008 DA - 2008// TI - Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant JO - J Oncol Pharm Pract VL - 14 UR - https://doi.org/10.1177/1078155208093930 DO - 10.1177/1078155208093930 ID - Howell2008 ER - TY - JOUR AU - Huitema, A. D. AU - Spaander, M. AU - Mathjt, R. A. AU - Tibben, M. M. AU - Holtkamp, M. J. AU - Beijnen, J. H. AU - Rodenhuis, S. PY - 2002 DA - 2002// TI - Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf052 DO - 10.1093/annonc/mdf052 ID - Huitema2002 ER - TY - JOUR AU - Huitema, A. D. AU - Smits, K. D. AU - Mathot, R. A. AU - Schellens, J. H. AU - Rodenhuis, S. AU - Beijnen, J. H. PY - 2000 DA - 2000// TI - The clinical pharmacology of alkylating agents in high-dose chemotherapy JO - Anti-Cancer Drugs VL - 11 UR - https://doi.org/10.1097/00001813-200008000-00002 DO - 10.1097/00001813-200008000-00002 ID - Huitema2000 ER - TY - JOUR AU - Duke, A. N. AU - Bigelow, G. E. AU - Lanier, R. K. AU - Strain, E. C. PY - 2011 DA - 2011// TI - Discriminative stimulus effects of tramadol in humans JO - J Pharmacol Exp Ther VL - 338 UR - https://doi.org/10.1124/jpet.111.181131 DO - 10.1124/jpet.111.181131 ID - Duke2011 ER - TY - JOUR AU - Jovanovic-Cupic, V. AU - Martinovic, Z. AU - Nesic, N. PY - 2006 DA - 2006// TI - Seizures associated with intoxication and abuse of tramadol JO - Clin Toxicol (Phila) VL - 44 UR - https://doi.org/10.1080/1556365050014418 DO - 10.1080/1556365050014418 ID - Jovanovic-Cupic2006 ER - TY - JOUR AU - Ripple, M. G. AU - Pestaner, J. P. AU - Levine, B. S. AU - Smialek, J. E. PY - 2000 DA - 2000// TI - Lethal combination of tramadol and multiple drugs affecting serotonin JO - Am J Forensic Med Pathol VL - 21 UR - https://doi.org/10.1097/00000433-200012000-00015 DO - 10.1097/00000433-200012000-00015 ID - Ripple2000 ER - TY - JOUR AU - Daubin, C. AU - Quentin, C. AU - Goulle, J. P. AU - Guillotin, D. AU - Lehoux, P. AU - Lepage, O. AU - Charbonneau, P. PY - 2007 DA - 2007// TI - Refractory shock and asystole related to tramadol overdose JO - Clin Toxicol (Phila) VL - 45 UR - https://doi.org/10.1080/15563650701438847 DO - 10.1080/15563650701438847 ID - Daubin2007 ER - TY - JOUR AU - Sansone, R. A. AU - Sansone, L. A. PY - 2009 DA - 2009// TI - Tramadol: seizures, serotonin syndrome, and coadministered antidepressants JO - Psychiatry (Edgmont) VL - 6 ID - Sansone2009 ER - TY - JOUR AU - Grond, S. AU - Sablotzki, A. PY - 2004 DA - 2004// TI - Clinical pharmacology of tramadol JO - Clin Pharmacokinet VL - 43 UR - https://doi.org/10.2165/00003088-200443130-00004 DO - 10.2165/00003088-200443130-00004 ID - Grond2004 ER - TY - JOUR AU - Tripepi, G. AU - Jager, K. J. AU - Dekker, F. W. AU - Zoccali, C. PY - 2010 DA - 2010// TI - Selection bias and information bias in clinical research JO - Nephron Clin Pract VL - 115 UR - https://doi.org/10.1159/000312871 DO - 10.1159/000312871 ID - Tripepi2010 ER -